You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: April 19, 2024

Medroxyprogesterone acetate - Generic Drug Details

✉ Email this page to a colleague

« Back to Dashboard

What are the generic drug sources for medroxyprogesterone acetate and what is the scope of patent protection?

Medroxyprogesterone acetate is the generic ingredient in seven branded drugs marketed by Pfizer, Amneal, Amphastar Pharms Inc, Cipla, Eugia Pharma, Hikma, Hong Kong, Mylan Labs Ltd, Sandoz, Sun Pharm, Teva Pharms Usa, Amarin Pharms, Solvay, Esi , Barr, Duramed Pharms Barr, and Upsher Smith Labs, and is included in twenty-five NDAs. Additional information is available in the individual branded drug profile pages.

There are nineteen drug master file entries for medroxyprogesterone acetate. Twenty-two suppliers are listed for this compound.

Summary for medroxyprogesterone acetate

US Patents:	0
Tradenames:	7
Applicants:	17
NDAs:	25
Drug Master File Entries:	19
Finished Product Suppliers / Packagers:	22
Raw Ingredient (Bulk) Api Vendors:	78
Clinical Trials:	121
Patent Applications:	7,178
Formulation / Manufacturing:	see details
Drug Prices:	Drug price trends for medroxyprogesterone acetate
What excipients (inactive ingredients) are in medroxyprogesterone acetate?	medroxyprogesterone acetate excipients list
DailyMed Link:	medroxyprogesterone acetate at DailyMed

See drug prices for medroxyprogesterone acetate

Recent Clinical Trials for medroxyprogesterone acetate

Identify potential brand extensions & 505(b)(2) entrants

Sponsor	Phase
Bezmialem Vakif University	N/A
Oregon Health and Science University	Early Phase 1
Peking University People's Hospital	Phase 2

See all medroxyprogesterone acetate clinical trials

Pharmacology for medroxyprogesterone acetate

Drug Class	Progestin

Medical Subject Heading (MeSH) Categories for medroxyprogesterone acetate

Antineoplastic Agents, Hormonal
Contraceptive Agents, Female
Contraceptive Agents, Male
Contraceptives, Oral, Synthetic

US Patents and Regulatory Information for medroxyprogesterone acetate

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Try a Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Hong Kong	MEDROXYPROGESTERONE ACETATE	medroxyprogesterone acetate	INJECTABLE;INJECTION	076553-001	Jul 28, 2004	AB	RX	No	No	⤷ Try a Trial	⤷ Try a Trial				⤷ Try a Trial
Pfizer	PROVERA	medroxyprogesterone acetate	TABLET;ORAL	011839-001	Approved Prior to Jan 1, 1982	AB	RX	Yes	No	⤷ Try a Trial	⤷ Try a Trial				⤷ Try a Trial
Barr	MEDROXYPROGESTERONE ACETATE	medroxyprogesterone acetate	TABLET;ORAL	040159-001	Aug 9, 1996	AB	RX	No	No	⤷ Try a Trial	⤷ Try a Trial				⤷ Try a Trial
Pfizer	PROVERA	medroxyprogesterone acetate	TABLET;ORAL	011839-003	Approved Prior to Jan 1, 1982	AB	RX	Yes	No	⤷ Try a Trial	⤷ Try a Trial				⤷ Try a Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Expired US Patents for medroxyprogesterone acetate

Subscribe to access the full database, or Try a Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Pfizer	DEPO-SUBQ PROVERA 104	medroxyprogesterone acetate	INJECTABLE;SUBCUTANEOUS	021583-001	Dec 17, 2004	⤷ Try a Trial	⤷ Try a Trial
Pfizer	DEPO-PROVERA	medroxyprogesterone acetate	INJECTABLE;INJECTION	012541-002	Approved Prior to Jan 1, 1982	⤷ Try a Trial	⤷ Try a Trial
Pfizer	DEPO-PROVERA	medroxyprogesterone acetate	INJECTABLE;INJECTION	012541-003	Approved Prior to Jan 1, 1982	⤷ Try a Trial	⤷ Try a Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.